$BDSI Company News Microsoft, Starbucks shares
Post# of 44845
Posted On: 06/09/2014 10:26:21 AM
$BDSI Company News
Microsoft, Starbucks shares rise after earnings reports 7:30 p.m. Jan. 23, 2014 - Wallace Witkowski
Top 10 U.S. cities for growing businesses 8:48 p.m. April 15, 2013 - Russ Britt
What 2012’s winners and losers say about 2013 7:00 a.m. Dec. 14, 2012 - Howard Gold
BioDelivery to get milestone payment; shares leap 12:54 p.m. Feb. 16, 2012 - MarketWatch.com
BioDelivery to get up to $180M in Endo Pharma pact 8:03 a.m. Jan. 6, 2012 - MarketWatch.com
Wednesday's biggest stock gainers and decliners 7:20 p.m. April 25, 2007 - MarketWatch
Updates, advisories and surprises 6:31 p.m. April 25, 2007 - MarketWatch
BioDelivery Sciences up 76% at $8.01 9:59 a.m. April 25, 2007 - Tomi Kilgore
BioDelivery Sciences Phase III trial shows positive results 6:39 a.m. April 25, 2007 - Simon Kennedy
BioDelivery Sciences says positive Phase III Fentanyl trial 6:12 a.m. April 25, 2007 - Steve Goldstein
Highlights of rising and falling U.S. stocks 6:15 p.m. March 2, 2006 - MarketWatch
BioDelivery Sciences off after nausea treatment setback 11:57 a.m. March 2, 2006 - Michael Baron
Highlights of rising and falling U.S. stocks 2:23 p.m. Sept. 30, 2005 - Michael Baron
BioDelivery prices 4.4 million shares at $2 each 8:21 a.m. Sept. 30, 2005 - Thomas Middleton
Biodelivery Sciences prices offer of 4.4M shares at $2 per 8:19 a.m. Sept. 30, 2005 - Michael Baron
BioDelivery prices 4.4M shares at $2 each 8:05 a.m. Sept. 30, 2005 - Thomas Middleton
BioDelivery Sciences:FDA to review nausea treatment app 10:49 a.m. July 20, 2005 - Carla Mozee
BioDelivery Sciences:FDA to review nausea treatment app 10:39 a.m. July 20, 2005 - Carla Mozee
BioDelivery Sciences: FDA accepts Emezine for review 10:38 a.m. July 20, 2005 - Carla Mozee
BioDelivery to get $7M for Phase III cancer-pain study 11:39 a.m. July 18, 2005 - Carla Mozee
BioDelivery Sciences International (BDSI): Heavy Pre-Market Activity 8:41 a.m. Today - TheStreet.com
The IBB Likely To Move Higher Along With These Biotechs With Catalysts Upcoming 8:30 a.m. June 2, 2014 - Seeking Alpha
BioDelivery Sciences International Inc Stock Downgraded (BDSI) 11:11 a.m. May 30, 2014 - TheStreet.com
Orexigen Will Run: Here's Why 3:47 p.m. May 27, 2014 - Seeking Alpha
2nd Half Of 2014 Biotechnology Catalysts: Part 1 9:34 a.m. May 27, 2014 - Seeking Alpha
Pipeline Update from BioDelivery Sciences - Analyst Blog 5:50 p.m. May 14, 2014 - Zacks.com
BioDelivery Sciences International's CEO Presents at Bank of America Merrill Lynch Healthcare Conference (Transcript) 6:35 a.m. May 14, 2014 - Seeking Alpha
BioDelivery Sciences International Inc Stock Upgraded (BDSI) 11:11 a.m. May 13, 2014 - TheStreet.com
2014 FDA Drug Approval Calendar 9:22 a.m. May 12, 2014 - TheStreet.com
Oversold Conditions For BioDelivery Sciences International (BDSI) 12:08 p.m. April 14, 2014 - TheStreet.com
BioDelivery Sciences' Clonidine in Phase III Study - Analyst Blog 6:25 p.m. April 4, 2014 - Zacks.com
BioDelivery Sciences: 4 Different Insiders Have Sold Shares This Month 3:45 a.m. March 31, 2014 - Seeking Alpha
BioDelivery Sciences and Quintiles Sign Deal for Bunavail - Analyst Blog 11:30 a.m. March 28, 2014 - Zacks.com
Pipeline Update from BioDelivery Sciences - Analyst Blog 5:00 p.m. March 18, 2014 - Zacks.com
BioDelivery Sciences reviews its business and updates milestones for 2014 9:01 a.m. March 14, 2014 - Seeking Alpha
10-K: BIODELIVERY SCIENCES INTERNATIONAL INC 6:14 a.m. March 14, 2014 - Edgar Online - (EDG = 10Q, 10K)
BioDelivery Sciences International (BDSI) Jumps: Stock Up 8.5% - Tale of the Tape 10:39 a.m. Feb. 11, 2014 - Zacks.com
3 Pharmaceutical Stocks to Buy Now 8:15 a.m. Jan. 31, 2014 - InvestorPlace.com
BioDelivery Sciences International (BDSI) Soars: Stock Up 50.6% - Tale of the Tape 9:51 a.m. Jan. 27, 2014 - Zacks.com
Can The Uptrend Continue for BioDelivery Sciences (BDSI)? - Tale of the Tape 8:01 a.m. Jan. 27, 2014 - Zacks.com
BioDelivery Sciences Receives FDA Approval for BUNAVAIL™ (buprenorphine and naloxone) Buccal Film for the Maintenance Treatment of Opioid Dependence 7:00 a.m. Today - PR Newswire - PRF
BioDelivery Sciences Receives FDA Approval for BUNAVAIL™ (buprenorphine and naloxone) Buccal Film for the Maintenance Treatment of Opioid Dependence 5:19 p.m. June 6, 2014 - PR Newswire - PRF
Technical Coverage on Top Gainers -- Research on Noranda Aluminum Holding, Teekay Tankers, BioDelivery Sciences Intl. and Quality Systems 6:00 a.m. May 27, 2014 - PR Newswire - PRF
BioDelivery Sciences Provides Business Review and Update in Conjunction with Filing of First Quarter 2014 Financials 6:00 p.m. May 8, 2014 - PR Newswire - PRF
BioDelivery Sciences to Present at the Bank of America Merrill Lynch 2014 Health Care Conference 7:00 a.m. May 8, 2014 - PR Newswire - PRF
BioDelivery Sciences Announces Randomization of Over 50% of Subjects in its Initial Phase 3 Study of Clonidine Topical Gel for Painful Diabetic Neuropathy 7:00 a.m. May 6, 2014 - PR Newswire - PRF
BioDelivery Sciences Announces Four BUNAVAIL Abstracts to be Presented at the 2014 American Society of Addiction Medicine Annual Conference 9:40 a.m. April 7, 2014 - PR Newswire - PRF
BioDelivery Sciences Announces Enrollment of the First Patient in a Phase 3 Clinical Study of Clonidine Topical Gel for Painful Diabetic Neuropathy 7:00 a.m. April 3, 2014 - PR Newswire - PRF
Foresite Capital Closes $300 Million Fund II to Finance Late-Stage Healthcare Companies 8:03 a.m. April 1, 2014 - BusinessWire - BZX
BioDelivery Sciences Announces Commercialization Agreement with Quintiles to Support the Launch of BUNAVAIL in the U.S. 7:00 a.m. March 27, 2014 - PR Newswire - PRF
BioDelivery Sciences Provides Business Review and Update in Conjunction with Filing of its 2013 Annual Report 6:30 a.m. March 14, 2014 - PR Newswire - PRF
Equities Hitting New High: Allergan, Aetna, Ecolab, and BioDelivery Sciences Intl. 12:17 p.m. March 12, 2014 - PR Newswire - PRF
BioDelivery Sciences to Present at the 26th Annual ROTH Conference 8:00 a.m. March 5, 2014 - PR Newswire - PRF
BioDelivery Sciences to Present at the Cowen and Company 34th Annual Health Care Conference 8:00 a.m. Feb. 28, 2014 - PR Newswire - PRF
BioDelivery Sciences Closes $60 Million Registered Direct Offering 8:00 a.m. Feb. 13, 2014 - PR Newswire - PRF
BioDelivery Sciences to Raise $60 Million in Registered Direct Offering From Institutional Investors 8:00 a.m. Feb. 10, 2014 - PR Newswire - PRF
BioDelivery Sciences Announces Four BUNAVAIL Abstracts to be Presented at the 2014 American Society of Addiction Medicine Annual Conference 8:00 a.m. Jan. 30, 2014 - PR Newswire - PRF
Endo and BioDelivery Sciences Announce Positive Top-Line Results from the Phase III Clinical Trial of BEMA Buprenorphine in Opioid Naive Patients with Chronic Pain 5:30 p.m. Jan. 23, 2014 - PR Newswire - PRF
BioDelivery Sciences Announces Hiring of David Acheson as Vice President of Sales and Managed Markets 9:30 a.m. Dec. 3, 2013 - PR Newswire
Positive FDA Meeting Confirms BDSI Phase 3 Program for Clonidine Topical Gel for Treatment of Painful Diabetic Neuropathy 8:00 a.m. Dec. 2, 2013 - PR Newswire
Microsoft, Starbucks shares rise after earnings reports 7:30 p.m. Jan. 23, 2014 - Wallace Witkowski
Top 10 U.S. cities for growing businesses 8:48 p.m. April 15, 2013 - Russ Britt
What 2012’s winners and losers say about 2013 7:00 a.m. Dec. 14, 2012 - Howard Gold
BioDelivery to get milestone payment; shares leap 12:54 p.m. Feb. 16, 2012 - MarketWatch.com
BioDelivery to get up to $180M in Endo Pharma pact 8:03 a.m. Jan. 6, 2012 - MarketWatch.com
Wednesday's biggest stock gainers and decliners 7:20 p.m. April 25, 2007 - MarketWatch
Updates, advisories and surprises 6:31 p.m. April 25, 2007 - MarketWatch
BioDelivery Sciences up 76% at $8.01 9:59 a.m. April 25, 2007 - Tomi Kilgore
BioDelivery Sciences Phase III trial shows positive results 6:39 a.m. April 25, 2007 - Simon Kennedy
BioDelivery Sciences says positive Phase III Fentanyl trial 6:12 a.m. April 25, 2007 - Steve Goldstein
Highlights of rising and falling U.S. stocks 6:15 p.m. March 2, 2006 - MarketWatch
BioDelivery Sciences off after nausea treatment setback 11:57 a.m. March 2, 2006 - Michael Baron
Highlights of rising and falling U.S. stocks 2:23 p.m. Sept. 30, 2005 - Michael Baron
BioDelivery prices 4.4 million shares at $2 each 8:21 a.m. Sept. 30, 2005 - Thomas Middleton
Biodelivery Sciences prices offer of 4.4M shares at $2 per 8:19 a.m. Sept. 30, 2005 - Michael Baron
BioDelivery prices 4.4M shares at $2 each 8:05 a.m. Sept. 30, 2005 - Thomas Middleton
BioDelivery Sciences:FDA to review nausea treatment app 10:49 a.m. July 20, 2005 - Carla Mozee
BioDelivery Sciences:FDA to review nausea treatment app 10:39 a.m. July 20, 2005 - Carla Mozee
BioDelivery Sciences: FDA accepts Emezine for review 10:38 a.m. July 20, 2005 - Carla Mozee
BioDelivery to get $7M for Phase III cancer-pain study 11:39 a.m. July 18, 2005 - Carla Mozee
BioDelivery Sciences International (BDSI): Heavy Pre-Market Activity 8:41 a.m. Today - TheStreet.com
The IBB Likely To Move Higher Along With These Biotechs With Catalysts Upcoming 8:30 a.m. June 2, 2014 - Seeking Alpha
BioDelivery Sciences International Inc Stock Downgraded (BDSI) 11:11 a.m. May 30, 2014 - TheStreet.com
Orexigen Will Run: Here's Why 3:47 p.m. May 27, 2014 - Seeking Alpha
2nd Half Of 2014 Biotechnology Catalysts: Part 1 9:34 a.m. May 27, 2014 - Seeking Alpha
Pipeline Update from BioDelivery Sciences - Analyst Blog 5:50 p.m. May 14, 2014 - Zacks.com
BioDelivery Sciences International's CEO Presents at Bank of America Merrill Lynch Healthcare Conference (Transcript) 6:35 a.m. May 14, 2014 - Seeking Alpha
BioDelivery Sciences International Inc Stock Upgraded (BDSI) 11:11 a.m. May 13, 2014 - TheStreet.com
2014 FDA Drug Approval Calendar 9:22 a.m. May 12, 2014 - TheStreet.com
Oversold Conditions For BioDelivery Sciences International (BDSI) 12:08 p.m. April 14, 2014 - TheStreet.com
BioDelivery Sciences' Clonidine in Phase III Study - Analyst Blog 6:25 p.m. April 4, 2014 - Zacks.com
BioDelivery Sciences: 4 Different Insiders Have Sold Shares This Month 3:45 a.m. March 31, 2014 - Seeking Alpha
BioDelivery Sciences and Quintiles Sign Deal for Bunavail - Analyst Blog 11:30 a.m. March 28, 2014 - Zacks.com
Pipeline Update from BioDelivery Sciences - Analyst Blog 5:00 p.m. March 18, 2014 - Zacks.com
BioDelivery Sciences reviews its business and updates milestones for 2014 9:01 a.m. March 14, 2014 - Seeking Alpha
10-K: BIODELIVERY SCIENCES INTERNATIONAL INC 6:14 a.m. March 14, 2014 - Edgar Online - (EDG = 10Q, 10K)
BioDelivery Sciences International (BDSI) Jumps: Stock Up 8.5% - Tale of the Tape 10:39 a.m. Feb. 11, 2014 - Zacks.com
3 Pharmaceutical Stocks to Buy Now 8:15 a.m. Jan. 31, 2014 - InvestorPlace.com
BioDelivery Sciences International (BDSI) Soars: Stock Up 50.6% - Tale of the Tape 9:51 a.m. Jan. 27, 2014 - Zacks.com
Can The Uptrend Continue for BioDelivery Sciences (BDSI)? - Tale of the Tape 8:01 a.m. Jan. 27, 2014 - Zacks.com
BioDelivery Sciences Receives FDA Approval for BUNAVAIL™ (buprenorphine and naloxone) Buccal Film for the Maintenance Treatment of Opioid Dependence 7:00 a.m. Today - PR Newswire - PRF
BioDelivery Sciences Receives FDA Approval for BUNAVAIL™ (buprenorphine and naloxone) Buccal Film for the Maintenance Treatment of Opioid Dependence 5:19 p.m. June 6, 2014 - PR Newswire - PRF
Technical Coverage on Top Gainers -- Research on Noranda Aluminum Holding, Teekay Tankers, BioDelivery Sciences Intl. and Quality Systems 6:00 a.m. May 27, 2014 - PR Newswire - PRF
BioDelivery Sciences Provides Business Review and Update in Conjunction with Filing of First Quarter 2014 Financials 6:00 p.m. May 8, 2014 - PR Newswire - PRF
BioDelivery Sciences to Present at the Bank of America Merrill Lynch 2014 Health Care Conference 7:00 a.m. May 8, 2014 - PR Newswire - PRF
BioDelivery Sciences Announces Randomization of Over 50% of Subjects in its Initial Phase 3 Study of Clonidine Topical Gel for Painful Diabetic Neuropathy 7:00 a.m. May 6, 2014 - PR Newswire - PRF
BioDelivery Sciences Announces Four BUNAVAIL Abstracts to be Presented at the 2014 American Society of Addiction Medicine Annual Conference 9:40 a.m. April 7, 2014 - PR Newswire - PRF
BioDelivery Sciences Announces Enrollment of the First Patient in a Phase 3 Clinical Study of Clonidine Topical Gel for Painful Diabetic Neuropathy 7:00 a.m. April 3, 2014 - PR Newswire - PRF
Foresite Capital Closes $300 Million Fund II to Finance Late-Stage Healthcare Companies 8:03 a.m. April 1, 2014 - BusinessWire - BZX
BioDelivery Sciences Announces Commercialization Agreement with Quintiles to Support the Launch of BUNAVAIL in the U.S. 7:00 a.m. March 27, 2014 - PR Newswire - PRF
BioDelivery Sciences Provides Business Review and Update in Conjunction with Filing of its 2013 Annual Report 6:30 a.m. March 14, 2014 - PR Newswire - PRF
Equities Hitting New High: Allergan, Aetna, Ecolab, and BioDelivery Sciences Intl. 12:17 p.m. March 12, 2014 - PR Newswire - PRF
BioDelivery Sciences to Present at the 26th Annual ROTH Conference 8:00 a.m. March 5, 2014 - PR Newswire - PRF
BioDelivery Sciences to Present at the Cowen and Company 34th Annual Health Care Conference 8:00 a.m. Feb. 28, 2014 - PR Newswire - PRF
BioDelivery Sciences Closes $60 Million Registered Direct Offering 8:00 a.m. Feb. 13, 2014 - PR Newswire - PRF
BioDelivery Sciences to Raise $60 Million in Registered Direct Offering From Institutional Investors 8:00 a.m. Feb. 10, 2014 - PR Newswire - PRF
BioDelivery Sciences Announces Four BUNAVAIL Abstracts to be Presented at the 2014 American Society of Addiction Medicine Annual Conference 8:00 a.m. Jan. 30, 2014 - PR Newswire - PRF
Endo and BioDelivery Sciences Announce Positive Top-Line Results from the Phase III Clinical Trial of BEMA Buprenorphine in Opioid Naive Patients with Chronic Pain 5:30 p.m. Jan. 23, 2014 - PR Newswire - PRF
BioDelivery Sciences Announces Hiring of David Acheson as Vice President of Sales and Managed Markets 9:30 a.m. Dec. 3, 2013 - PR Newswire
Positive FDA Meeting Confirms BDSI Phase 3 Program for Clonidine Topical Gel for Treatment of Painful Diabetic Neuropathy 8:00 a.m. Dec. 2, 2013 - PR Newswire
(0)
(0)Scroll down for more posts ▼